M&A M&A
Glenmark acquires Acetylcysteine injection from Aspen Pharma
Source Business Line (opens in a new tab)BSE Announcement (opens in a new tab)
Mumbai-based Glenmark Pharmaceuticals has acquired the Abbreviated New Drug Application (ANDA) for the product Acetylcysteine Injection, Single-Dose Vials from Aspen Pharma USA Inc . and launched in the US market. The drug is a generic version developed by Cumberland Pharmaceuticals Inc.